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Background: Benzodiazepines have a hypnotic/sedative effect through the inhibitory action of γ-aminobutyric acid 
type A receptor. Flumazenil antagonizes these effects via competitive inhibition, so it has been used to reverse the 
effect of benzodiazepines. Recently, flumazenil has been reported to expedite recovery from propofol/remifentanil 
and sevoflurane/remifentanil anesthesia without benzodiazepines. Endogenous benzodiazepine ligands 
(endozepines) were isolated in several tissues of individuals who had not received benzodiazepines.
Methods: Forty-five healthy unpremedicated patients were randomly allocated to either flumazenil or a control 
groups. Each patient received either a single dose of 0.3 mg of flumazenil (n = 24) or placebo (n = 21). After drug 
administration, various recovery parameters and bispectral index (BIS) values in the flumazenil and control groups 
were compared. 
Results: Mean time to spontaneous respiration, eye opening on verbal command, hand squeezing on verbal 
command, extubation and time to date of birth recollection were significantly shorter in the flumazenil group than 
in the control group (P = 0.004, 0.007, 0.005, 0.042, and 0.016, respectively). The BIS value was significantly higher in 
flumazenil group than in the control group beginning 6 min after flumazenil administration.
Conclusions: Administration of a single dose of 0.3 mg of flumazenil to healthy, unpremedicated patients at the end 
of sevoflurane/fentanyl anesthesia without benzodiazepines resulted in earlier emergence from anesthesia and an 
increase in the BIS value. This may indicate that flumazenil could have an antagonistic effect on sevoflurane or an 
analeptic effect through endozepine-dependent mechanisms. (Korean J Anesthesiol 2012; 62: 19-23)
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Introduction
Benzodiazepines can cause sedation and amnesia by 
affecting the central nervous system. The effect of benzodiaze-
pines is exerted at the specific binding site of the γ-aminobutyric 
acid type A (GABA-A) receptor. The receptor is responsible 
for a major inhibitory effect on anesthesia [1,2]. Flumazenil, a 
benzodiazepine antagonist, has a dose-dependent antagonistic 
effect on all of the actions of benzodiazepines, including 
sedation, amnesia and respiratory depression via competitive 
inhibition at the benzodiazepine binding site on the GABA-A 
receptor [3]. For this reason, flumazenil is used for the purpose 
of antagonism in general anesthesia when a benzodiazepine is 
used [4], but recently, a few studies have been performed testing 
the effect of flumazenil on recovery from general anesthesia 
in which no benzodiazepines were used. For example, there 
have been reports demonstrating a positive effect of flumazenil 
injection on recovery from general anesthesia that did not 
include benzodiazepine medication [5,6]. Additionally, a few 
studies have reported on the effect of inhalation anesthetics, 
including sevoflurane, on the GABA-A receptor [7-9]. Therefore, 
we conducted this study with the assumption that flumazenil 
may affect the recovery parameters and BIS of sevoflurane/
fentanyl general anesthesia.
Materials and Methods
This study included 45 patients at or below the age of 67 and 
with an American Society of Anesthesia physical status class 1 
or 2, who were undergoing an operation expected to take one or 
two hours. Those whose body mass index was lower than 18 kg/
m
2 or higher than 30 kg/m
2, those who had diseases that might 
affect the level of consciousness, such as stroke and dementia, 
those who had been undergoing treatment for a cardiovascular 
disease or taking a sedative or somnifacient, and those whose 
blood loss was expected to be more than 1 L were excluded 
from this study. This study was approved by the Hospital 
Ethics Committee. An explanation of the study was provided 
to all subjects and written consents were received from them 
before the operation. Except for sex, there were no significant 
differences in the demographic data between the two groups 
including body mass index, preanesthetic systolic and diastolic 
blood pressure, heart rate, oxygen saturation, duration of 
operation, blood loss and fentanyl dose (Table 1).
The subjects were not premedicated. After arrival in the 
operating room, the subjects’ blood pressure, heart rate, 
electrocardiograph, peripheral oxygen saturation and BIS were 
continuously measured using a patient monitoring instrument. 
Before the induction of anesthesia, glycopyrrolate 0.2 mg was 
injected intravenously. Thiopental sodium (4 mg/kg), fentanyl 
(2 μg/kg), rocuronium (0.6 mg/kg) and sevoflurane (2-4 
vol/%) were used for anesthetic induction. An esophageal 
thermometer was inserted to monitor body temperature, and 
train-of-four stimulation (TOF) monitoring was performed. 
Oxygen and nitrous oxide were administered each at the rate 
of 1.5 L/min, and the expiratory sevoflurane concentration was 
kept at 1.5 vol/%. The anesthesia was maintained while keeping 
the expiratory carbon dioxide pressure at 30-40 mmHg. The 
BIS was maintained at around 40 throughout the operation. 
In order to maintain the hemodynamic parameters, including 
blood pressure and heart rate, within 20% of those measured 
before the induction, fentanyl (0.5-1.0 μg/kg) was injected if 
necessary during the operation. To maintain T1 in the TOF ratio 
(T4 : T1) at 25%, rocuronium (0.2 mg/kg) was intravenously 
injected with the top-up dose. The patient’s fluid levels were 
maintained with crystalloid solution. The blood loss, calculated 
by measuring the weight of aspiratory vessels and gauze, was 
compensated with 6% hydroxyethyl starch (130/0.4) (Voluven, 
Table 1. Patient’s Characteristics and Preoperative Hemodynamics
Flumazenil group (n = 24) Control group (n = 21)
Patient’s characteristics
    M/F
    Age (yr)
    Weight (kg)
    Height (cm)
    BMI (kg/m
2)
    Duration of surgery (hr)
    Surgical blood loss (ml)
    Fentanyl used during surgery (μg/kg)
Preoperative hemodynamics
    Systolic blood pressure (mmHg)
    Diastolic blood pressure (mmHg)
    Heart rate (beats/min)
    SpO2 (%)
2/22
40.4 ± 10.3
57.7 ± 7.4
160.0 ± 5.8
22.5 ± 1.7
1.7 ± 0.6
50.8 ± 41.7
3.0 ± 0.8
131.1 ± 16.5
77.0 ± 11.3
79.8 ± 17.9
98.9 ± 0.6
5/16
41.8 ± 14.2
56.6 ± 7.9
163.3 ± 7.9
21.1 ± 2.7
1.6 ±0.7
36.2 ± 32.0
3.1 ± 0.8
122.0 ± 20.1
73.9 ± 10.0
80.7 ± 12.7
98.9 ± 0.6
Data are expressed as means ± SD. BMI: body mass index. 21 www.ekja.org
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Fresenius Kabi, Bad Homburg, Germany). A heating blanket 
(Bair Hugger Warming unit-Model. 505, Arizant healthcare, 
USA) was used to keep the patient’s body temperature at or 
higher than 36
oC.
End of the operation was the last skin suture and an 
intravenous injection of fentanyl (0.5 μg/kg) was given five 
minutes before the expected end of the operation while 
sevoflurane was continuously administered without reducing 
the concentration for pain alleviation. The reversal of muscular 
relaxation (TOF 0.9) was induced using pyridostigmine. 
At the end of the operation, sevoflurane and nitrous oxide 
were stopped and flumazenil (0.3 mg, in 3 ml volume) or 
normal saline (3 ml) was intravenously injected while oxygen 
supply was increased and hyperventilation was performed. 
Doctors and nurses of the Anesthesiology and Pain Medicine 
Department participating in the anesthesia were blinded to 
treatment.
After termination of the anesthesia, the time taken to 
spontaneous respiration while attempting to awaken the patient 
with the same words in 20-second intervals as well as hand 
squeezing and eye opening on verbal command, extubation 
of the endotracheal tube and recollection of their date of birth 
were measured; BIS values were also recorded in two-minute 
intervals. The patient was then transferred to the recovery room 
and carefully monitored for one hour by medical staff who had 
not participated in the anesthesia. The patient was discharged 
from the recovery room and transferred to the ward according 
to general standards.
Statistical analysis was performed using SPSS software 
(version 18.0, SPSS Inc., Chicago, IL). The parameters related to 
the recovery from general anesthesia and the BIS values were 
expressed as means ± standard deviation (SD). A normality 
test was performed with respect to each of the parameters to 
compare the time to reach the index representing recovery 
from anesthesia between the two groups. After verifying that 
the parameters satisfied normality, a two-sample t-test was 
performed. To compare the BIS values over time between 
the two groups, we performed a two-way ANOVA followed 
by a Bonferroni posthoc test. A P value of less than 0.05 was 
considered significant.
Results
The mean time taken to spontaneous respiration, hand 
squeezing and eye opening on verbal command, extubation 
of the endotracheal tube and recollection of their date of birth 
was significantly shorter in the flumazenil injection group than 
in the control group (Table 2). The BIS values at zero, two, and 
four minutes after the intravenous injection of flumazenil or 
normal saline at the end of the operation were not significantly 
different, but the values at six, eight, ten, and twelve minutes 
were significantly higher in the experimental group than in the 
control group. The values did not show a significant difference 
at 14 and 16 minutes after the injection (Fig. 1).
Discussion
Flumazenil, which has an antagonist effect on benzodia-
zepines, can be used when a patient is overly sedated from 
excessive medication with benzodiazepines or fails to recover 
from amnesia following an operation [8]. Specifically, this 
effect of flumazenil is caused by competitive inhibition of 
the GABA-A receptor, a target for benzodiazepines [4]. In this 
study, sevoflurane/fentanyl anesthesia was carried out in 
unpremedicated patients who were not given benzodiazepines 
and the results showed that injection of flumazenil at the end of 
anesthesia significantly reduced the time taken to recovery from 
the anesthesia and increased the BIS value when compared to 
the control group.
A previous study had shown that flumazenil itself does 
not have such an effect: 0.3 mg of flumazenil was injected to 
a control group or a group that had received midazolam and 
the auditory and somatosensory evoked cortical reaction 
Fig. 1. Data are means ± SD. Two-way ANOVA with Bonferroni’s post-
hoc test determined significant differences in BIS between the two 
groups from 6 to 12 min after flumazenil administration. *Indicates P 
< 0.05 between the groups. 
†Indicates P < 0.01 between the groups.
Table 2.  Recovery Parameters
Time (min) from administration  
of flumazenil or placebo to
Flumazenil 
group
(n = 24)
Control 
group
(n = 21)
P
Spontaneous breathing
Eye opening on verbal command
Hand squeezing on verbal command
Extubation
Date of birth recollection
5.7 ± 0.8
6.3 ± 0.9
7.1 ± 1.0
8.0 ± 1.0
8.5 ± 1.1
6.4 ± 0.7
7.2 ± 1.1
8.0 ± 1.1
8.7 ± 1.1
9.3 ± 1.1
0.004
0.007
0.005
0.042
0.016
Data are expressed as means ± SD. 22 www.ekja.org
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was increased only in the midazolam-treated group, with 
no changes in the non-injection group [10]. Thus, it can be 
presumed that flumazenil may have the effect to help recovery 
from anesthesia by antagonizing certain mechanism(s) of 
general anesthesia.
Several studies have reported on the antagonistic effect 
of flumazenil on anesthetics other than benzodiazepines. 
Weinbroum and Geller [11] injected flumazenil for recovery from 
halothane, enflurane and isoflurane anesthesia, and reported 
an improvement in the cognitive and motor abilities as well as 
the subjective feelings of the patients. Roald et al. [12] found 
a significant increase in the cerebral metabolic rate of oxygen 
(CMRO2) when flumazenil was injected to dogs anesthetized 
with isoflurane, but not in the non-anesthetized dogs and 
concluded that flumazenil has a partial antagonizing effect on 
isoflurane. Recently, Dahaba et al. [5] reported that flumazenil 
injection enhanced the recovery from propofol/remifentanil 
anesthesia and significantly increased the BIS value.
On the other hand, there are studies reporting the opposite 
result. In an experiment with mice, Murayama et al. [13] 
reported that flumazenil did not antagonize the effects of 
halothane, thiamylal and propofol. Schwieger et al. [14] injected 
flumazenil at doses ranging from 0.5-4.5 mg/kg in dogs 
anesthetized with enflurane, isoflurane and enflurane/fentanyl, 
and reported that the injection did not affect the minimal 
alveolar concentration (MAC) of the inhalation anesthetics or 
the plasma fentanyl concentration. Moreover, Schwartz et al. [15] 
reported that flumazenil injection in dogs anesthetized with 
isoflurane anesthesia may play the role of an agonist and not an 
antagonistin reducing the MAC.
Another hypothesis is that flumazenil might help recovery 
from anesthesia by antagonizing intrinsic benzodiazepines (or 
benzodiazepine-like ligands), not extrinsic benzodiazepines. 
The spontaneous endozepines or intrinsic benzodiazepine 
receptor ligands were extracted from various mammalian 
tissues that had not been exposed to benzodiazepines [16]. 
In particular, intrinsic benzodiazepines were detected in the 
cerebrospinal fluid, plasma and serum of humans who had not 
taken benzodiazepines, and even in the breast milk of a healthy 
woman who had never taken benzodiazepines immediately 
after child-birth [17-20]. Additionally, there was a report that 
a considerable amount of benzodiazepine-like ligands were 
detected in the brain of a hepatic encephalopathy patient who 
had not previously been exposed to benzodiazepines [20]. 
A later study conducted on the basis of this result showed 
that injection of flumazenil to a hepatic encephalopathy 
patient who had not been given benzodiazepines resulted in 
electroencephalographic improvements [21].
According to a previous study on the effect of flumazenil 
injection on general anesthesia performed without using 
benzodiazepines, injection of 0.5 mg of flumazenil 30 minutes 
before the end of the operation, in a patient undergoing 
general anesthesia with propofol/remifentanil, resulted in 
the increase of the BIS value and later had a positive effect 
on the parameters for recovery from anesthesia [5]. In our 
study, 0.3 mg of flumazenil was injected just before the end 
of the operation and there was a significant [positive] effect 
on the recovery, but the effect was smaller than in the study 
mentioned previously. Although it is not accurately known 
how propofol and sevoflurane act on the GABA-A receptor to 
produce the anesthetic effect, a recent study suggested that they 
have different active sites on the GABA-A receptor [22]. When 
flumazenil is clinically used to antagonize benzodiazepines, 
it takes effect in about 1-5 minutes. If flumazenil is injected 
at 1 mg to obtain the desired consciousness level, the effect is 
maintained for about 2 hours and the duration is proportional 
to the dose [23]. If the faster recovery from anesthesia [in 
the studies we discuss here] was achieved by flumazenil 
antagonizing the actions of propofol or sevoflurane on the 
GABA-A receptor, the difference in the results can be explained 
by the fact that the two anesthetics have different active sites 
and the dose was different. Moreover, the significant increase 
of the BIS value in the experimental group in comparison to the 
control group at six minutes after flumazenil injection in the 
present study might have been because of the rapid expression 
of the flumazenil effect. The difference in the BIS value was no 
longer significant from 14 minutes after the injection, which 
might have been because the effect of the small amount of 
flumazenil used (0.3 mg) disappeared and the sevoflurane used 
for the anesthesia was no longer present in both groups.
Different from the study where the injection was performed 
30 minutes before the end of the anesthesia, there was a 
study in which flumazenil was injected just before the end of 
the operation to investigate the effect on recovery, but only 
the time taken to the appearance of the recovery parameters 
was measured, without measuring the BIS value [6]. Since 
BIS decreases in a dose-dependent manner with respect 
to various anesthetics such as propofol, sevoflurane, and 
midazolam among others, it allows for measurement of the 
depth of anesthesia with these anesthetics [24], and is useful for 
measuring the degree of awareness after general anesthesia [25]. 
Thus, different from the previous study where only the recovery 
parameters were examined, we were able to obtain more 
objective information about the recovery by also measuring the 
BIS value.
In conclusion, this study showed that injection of flumazenil 
to unpremedicated patients anesthetized with sevoflurane/
fentanyl could help in recovery from the anesthesia. This 
effect may be because flumazenil antagonizes the action of 
sevoflurane or intrinsic benzodiazepines. However, a large-scale 23 www.ekja.org
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study to verify our findings may be required to more accurately 
determine the effect and safety of flumazenil on recovery from 
general anesthesia.
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